Table 1.
Demographic characteristics of 14–34 year old women with HPV results by region, NHANES data 2003–2014 (N=6,387)
| Overall (N=6,387) | Northeast a (n=931) | Midwest a (n=1,259) | South a (n=2,458) | West a (n=1,739) | |||
|---|---|---|---|---|---|---|---|
| Weighted n | w% (95% CI) | w% (95% CI) | w% (95% CI) | w% (95% CI) | w% (95% CI) | p-value | |
| Age | 0.13 | ||||||
| 14–19 | 9,588,789 | 26.9 (25.4–28.4) | 25.4 (22.6–28.3) | 30.2 (26.4–33.9) | 26.4 (23.7–29.1) | 25.7 (23.1–28.3) | |
| 20–29 | 17,483,814 | 49.1 (47.2–50.9) | 47.3 (43.3–51.2) | 46.9 (42.9–50.9) | 49.4 (46.4–52.4) | 51.6 (48.3–55.0) | |
| 30–34 | 8,551,157 | 24.0 (22.5–25.5) | 27.3 (23.0–31.6) | 22.9 (19.8–26.0) | 24.2 (21.5–26.8) | 22.7 (20.2–25.2) | |
| Race/ethnicity | <0.001 | ||||||
| Non-Hispanic white | 21,583,883 | 60.6 (57.4–63.8) | 68.3 (60.1–76.6) | 75.8 (70.0–81.6) | 51.0 (45.2–56.8) | 55.6 (48.9–62.3) | |
| Non-Hispanic black | 5,050,542 | 14.2 (12.2–16.2) | 10.9 (6.5–15.3) | 11.1 (7.4–14.9) | 24.1 (19.7–28.5) | 5.0 (3.4–6.7) | |
| Mexican American | 4,124,698 | 11.6 (9.8–13.4) | 1.9 (0.8–2.9) | 5.0 (3.3–6.8) | 12.5 (8.6–16.4) | 22.1 (17.4–26.8) | |
| Other Hispanic | 2,298,628 | 6.4 (5.3–7.6) | 12.8 (8.0–17.6) | 1.8 (0.7–2.9) | 6.8 (5.1–8.6) | 6.2 (4.6–7.8) | |
| Other | 2,566,009 | 7.2 (6.2–8.2) | 6.1 (4.2–8.0) | 6.2 (4.2–8.2) | 5.5 (4.0–7.1) | 11.1 (8.5–13.7) | |
| Marital Status | 0.25 | ||||||
| Never married | 18,032,758 | 52.2 (49.8–54.5) | 51.5 (46.9–56.0) | 53.8 (50.1–57.4) | 53.7 (49.0–58.5) | 48.9 (45.4–52.5) | |
| Living together | 4,175,129 | 12.1 (10.9–13.3) | 13.3 (9.9–16.7) | 12.9 (10.7–15.1) | 11.4 (9.2–13.6) | 11.4 (9.2–13.7) | |
| Married | 10,561,770 | 30.6 (28.4–32.7) | 28.9 (24.8–33.1) | 29.6 (25.9–33.2) | 29.8 (25.8–33.9) | 33.4 (29.4–37.4) | |
| Widowed/divorced/ separated | 1,801,280 | 5.2 (4.4–6.0) | 6.3 (4.7–7.8) | 3.7 (2.4–5.0) | 5.0 (3.7–6.3) | 6.2 (4.3–8.1) | |
| Age at first sex | 0.04 | ||||||
| Never | 5,843,936 | 17.8 (16.6–19.0) | 16.6 (14.1–19.1) | 18.9 (16.5–21.3) | 16.6 (14.4–18.6) | 19.3 (16.8–21.8) | |
| <14 y | 2,456,010 | 7.5 (6.6–8.3) | 7.0 (5.3–8.8) | 7.9 (5.3–10.4) | 8.8 (7.6–10.1) | 5.5 (4.3–6.7) | |
| 14–18 y | 19,250,352 | 58.6 (56.6–60.6) | 62.6 (59.0–66.2) | 57.0 (53.1–60.9) | 59.4 (56.5–62.4) | 56.6 (51.6–61.5) | |
| 19+ y | 5,286,360 | 16.1 (14.6–17.6) | 13.8 (10.5–17.0) | 16.2 (12.9–19.5) | 15.2 (12.9–17.4) | 18.6 (14.9–22.4) | |
| Lifetime male sex partners | <0.001 | ||||||
| 0 | 5,985,675 | 18.5 (17.2–19.8) | 17.2 (14.5–20.0) | 19.4 (16.9–21.9) | 17.5 (15.4–19.6) | 19.9 (17.3–22.4) | |
| 1–2 | 8,015,800 | 24.8 (23.3–26.3) | 19.8 (16.7–23.0) | 23.8 (21.1–26.5) | 24.2 (22.1–26.4) | 29.4 (25.8–33.0) | |
| >3 | 18,315,613 | 56.7 (54.9–58.4) | 62.9 (59.5–66.3) | 56.8 (53.9–59.7) | 58.2 (55.6–60.9) | 50.7 (46.4–55.1) | |
| Time period | |||||||
| Pre-vaccine cycle (2003–2006) | 11,763,709 | 33.0 (30.5–35.5) | 32.8 (23.0–42.6) | 35.0 (26.0–44.1) | 32.6 (27.8–37.4) | 32.0 (23.8–40.2) | 0.96 |
| Post-vaccine cycle (2007–2014) | 23,860,051 | 67.0 (64.5–69.5) | 67.2 (57.4–77.0) | 65.0 (55.9–77.0) | 67.4 (62.6–72.2) | 68.0 (59.8–76.2) | |
| HPV vaccine in post-licensure years (2007–2014, n=3,732) | 0.06 | ||||||
| 0 doses | 17,635,474 | 75.4 (73.7–77.9) | 69.8 (64.2–75.3) | 74.8 (70.2–79.5) | 77.5 (74.0–81.0) | 77.9 (74.0–81.7) | |
| >1 dose | 5,635,365 | 24.2 (22.1–26.3) | 30.2 (24.7–35.7) | 25.2 (20.5–29.8) | 22.5 (19.0–25.9) | 22.1 (18.3–26.0) | |
| HPV vaccine dose numberbin post-licensure years (2007–2014, n=3,696) | 0.05 | ||||||
| 1 dose | 851,584 | 3.7 (3.2–4.2) | 3.0 (2.3–3.6) | 3.4 (2.4–4.4) | 4.0 (3.1–5.0) | 3.9 (2.7–5.1) | |
| 2 dose | 1,098,454 | 4.8 (3.8–5.7) | 6.6 (4.0–9.2) | 5.2 (2.3–8.0) | 3.5 (2.2–4.8) | 5.0 (3.5–6.5) | |
| 3 dose | 3,482,258 | 15.1 (13.3–16.9) | 19.7 (14.7–24.7) | 16.4 (12.6–20.2) | 14.0 (11.0–17.0) | 12.7 (9.2–16.2) | |
w% = weighted prevalence, 95% CI = 95% confidence interval
Northeast states=Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont; Midwest states=Indiana, Illinois, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, Wisconsin; South states=Arkansas, Alabama, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, West Virginia; West=Alaska, Arizona, California, Colorado, Hawaii, Idaho, Nevada, New Mexico, Oregon, Washington, Wyoming.
Some data were missing due to non-response among respondents who had received at least 1 HPV vaccine dose. HPV=human papillomavirus; NHANES=National Health and Nutrition Examination Survey